PatrickWalshMcGarrahMD

Gastrointestinal Cancer, Head & Neck Cancer

Physician

Dr. McGarrah is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
200 1st St SW
Rochester, MN 55905
Phone+1 507-293-3619

Fax+1 507-284-0702

Mayo Clinic College of Medicine and Science (Rochester)Residency, Internal Medicine, 2017 - 2020
University of Minnesota Medical SchoolClass of 2017

PubMed

25 citations
Targeting cytochrome P450-dependent cancer cell mitochondria: cancer associated CYPs and where to find them
Zhijun Guo, Veronica Johnson, Jaime Barrera, Mariel Porras, Diego Hinojosa
Cancer Metastasis Reviews. 2018-09-01
27 citations
Treatment Outcomes of Well-Differentiated High-Grade Neuroendocrine Tumors.
Alex J. Liu, Benjamin E. Ueberroth, Patrick W. McGarrah, Skye A. Buckner Petty, Ayse Tuba Kendi
The Oncologist. 2021-05-01
12 citations
Efficacy of Checkpoint Inhibitors in Neuroendocrine Neoplasms: Mayo Clinic Experience.
Jennifer Gile, Alex J. Liu, Patrick W. McGarrah, Rachel A. Eiring, Timothy J. Hobday
Pancreas. 2021-04-01

Lectures

Efficacy of somatostatin analog (SSA) monotherapy for well-differentiated grade 3 (G3) gastroenteropancreatic neuroendocrine tumors (NETs).
ASCO Gastrointestinal Cancers Symposium - San Francisco, CA - 1/24/2020

Capecitabine for Salvage Treatment of Patients with Heavily Pretreated Human Papillomavirus–Associated Oropharynx Cancer with Distant MetastasesJanuary 16th, 2024